Novel immune-response related gene profile is associated with pathological complete response after neoadjuvant chemotherapy in primary breast cancer patients

First Author / 第一作者

Chun-Yu Liu

Institution / 單位

Taipei Veterans General Hospital

Audio / 音訊檔

Author Group / 作者群

Chun-Yu Liu, M.D.-Ph.D. 1,2,3,4 Chi-Cheng Huang, M.D.-Ph.D.3,5,6 Yi-Fang Tsai, M.D.-Ph.D.3,4,6, Ta-Chung Chao, M.D.-Ph.D.1,3,4, Yen-Shu Lin, M.D.3,6, Chin-Jung Feng, M.D.3, Jiun-I Lai, M.D.-Ph.D.1,3,4, Ji-Lin Chen, Ph.D.3, Yen-Jen Chen, M.D.3,4,6, Jen-Hwey Chiu, M.D.-Ph.D.3,6,7, Chih-Yi Hsu, M.D.4,8, Ling-Ming Tseng, M.D.3,4,6,9,*

Author Group Institution/ 作者群單位

1Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan 2Division of Transfusion Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan 3Comprehensive Breast Health Center, Taipei Veterans General Hospital, Taipei, Taiwan 4School of Medicine, National Yang Ming Chiao Tung University, Hsinchu, Taiwan 5Department of Public Health, College of Public Health, National Taiwan University, Taipei, Taiwan 6Division of General Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan 7Institute of Traditional Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan 8Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan 9Division of Experimental Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan

Category / 主題分類

Clinical Research

Keyword / 關鍵字

breast cancer, neoadjuvant chemotherapy, pathological complete response

Back to list